Non-invasive prenatal testing (NIPT) is a screening method used during pregnancy to identify the risk of certain chromosomal abnormalities in the fetus. Whether health insurance plans provide financial assistance for this service is a frequent inquiry among expectant parents. The availability of coverage significantly affects accessibility to this advanced screening option.
Access to prenatal genetic screening offers expectant parents and their healthcare providers valuable information for informed decision-making regarding the pregnancy. Understanding potential risks early allows for enhanced prenatal care, potential planning for the child’s future medical needs, and can alleviate anxiety. Historically, such tests were reserved for high-risk pregnancies, but their increasing accuracy and non-invasive nature have led to wider adoption and debate about broader coverage.